Your browser doesn't support javascript.
loading
Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer's Disease.
He, Chuan; Huang, Zhong-Sheng; Yu, Chao-Chao; Wang, Hai-Hua; Zhou, Hua; Kong, Li-Hong.
Afiliação
  • He C; Hubei University of Chinese Medicine, Wuhan, 430060, China.
  • Huang ZS; Hubei University of Chinese Medicine, Wuhan, 430060, China.
  • Yu CC; Department of Tuina, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, 518000, China.
  • Wang HH; The 4th Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, 518000, China.
  • Zhou H; Hospital of Traditional Chinese Medicine of Fengrun District, Tangshan, 064000, China.
  • Kong LH; Hubei University of Chinese Medicine, Wuhan, 430060, China. 11300284@qq.com.
Curr Med Sci ; 40(6): 1022-1030, 2020 Dec.
Article em En | MEDLINE | ID: mdl-33428129
ABSTRACT
Senile plaques (SPs) are one of the pathological features of Alzheimer's disease (AD) and they are formed by the overproduction and aggregation of amyloid-beta (Aß) peptides derived from the abnormal cleavage of amyloid precursor protein (APP). Thus, understanding the regulatory mechanisms during Aß metabolism is of great importance to elucidate AD pathogenesis. Recent studies have shown that epigenetic modulation-including DNA methylation, non-coding RNA alterations, and histone modifications-is of great significance in regulating Aß metabolism. In this article, we review the aberrant epigenetic regulation of Aß metabolism.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos beta-Amiloides / Precursor de Proteína beta-Amiloide / Epigênese Genética / Doença de Alzheimer Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos beta-Amiloides / Precursor de Proteína beta-Amiloide / Epigênese Genética / Doença de Alzheimer Idioma: En Ano de publicação: 2020 Tipo de documento: Article